Sign in
4

Changes in Ownership

ImmunityBio, Inc. Filed Acc 0001326110-23-000106

Options or other derivatives

  • Chief Financial Officer acquired 141,489 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Sachs David C. Chief Financial Officer 2023-08-25 Grant or award · Restricted Stock Units +141,489 141,489 D
Loading xslF345X05/wk-form4_1693270702.xml…